Cargando…

Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma

PURPOSE: To describe the efficacy and safety of brolucizumab (Beovu®, Novartis Pharmaceuticals) in a case of cystoid macular edema associated with radiation retinopathy as a result of iodine-125 plaque brachytherapy (PBT) for choroidal melanoma, resistant to treatment with other anti-vascular endoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villegas, Natacha C., Mishra, Kapil, Steinle, Nathan, Liu, Wu, Beadle, Beth, Mruthyunjaya, Prithvi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121253/ https://www.ncbi.nlm.nih.gov/pubmed/35599950 http://dx.doi.org/10.1016/j.ajoc.2022.101581

Ejemplares similares

Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Displacement of submacular hemorrhage with intravitreal tissue plasminogen activator following 27 gauge transvitreal fine needle aspiration biopsy for choroidal melanoma
por: Narala, Ramsudha, et al.
Publicado: (2022)

Marked Choroidal Thinning Observed after Intravitreal Brolucizumab Injection
por: Ueta, Yoshiki, et al.
Publicado: (2023)

Choroidal Effusion following Intravitreal Brolucizumab Injection: A Case Report
por: Sim, Ha Eun, et al.
Publicado: (2022)

Immediate onset of sterile endophthalmitis with hypopyon after intravitreal Brolucizumab in a case of polypoidal choroidal vasculopathy
por: Narayanan, Raja, et al.
Publicado: (2021)

One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy
por: Ito, Arisa, et al.
Publicado: (2022)

Effect of Intravitreal Brolucizumab in the Treatment of Polypoidal Choroidal Vasculopathy With Foveal Lipid Exudation
por: Carta, Valentina, et al.
Publicado: (2023)

The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
por: Bae, Ki Woong, et al.
Publicado: (2022)

Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
por: Russo, Andrea, et al.
Publicado: (2012)

Advanced Coats’ disease treated with intravitreal brolucizumab combined with laser photocoagulation
por: Patel, Nimesh A., et al.
Publicado: (2020)

Widefield imaging of retinal and choroidal tumors
por: Callaway, Natalia F., et al.
Publicado: (2019)

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation
por: Shigemoto, Yumi, et al.
Publicado: (2021)

Regression patterns of choroidal melanoma: After palladium-103 ((103)Pd) plaque brachytherapy
por: Maheshwari, Abhilasha, et al.
Publicado: (2018)

Adolescent Plaque Brachytherapy for Large Choroidal Metastasis from Lung Carcinoid Tumor
por: Crespo, Marcos A., et al.
Publicado: (2021)

Endoscopic enucleation and clinicopathologic correlation of a small choroidal melanoma hiding massive extrascleral extension()
por: Yu, Michael D., et al.
Publicado: (2023)

Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
por: Houston, Samuel K, et al.
Publicado: (2013)

Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration
por: Haug, Sara J., et al.
Publicado: (2020)

Retinal pigment epithelial tear following intravitreal injection of brolucizumab
por: Ashkenazy, Noy, et al.
Publicado: (2021)

Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2021)

Contralateral Effect following Intravitreal Brolucizumab Injection in Diabetic Macular Edema
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Response of extra-large pigment epithelial detachment to intravitreal brolucizumab injection
por: Chakraborty, Somnath, et al.
Publicado: (2023)

Multimodal imaging in non-paraneoplastic autoimmune retinopathy
por: Kasongole, David, et al.
Publicado: (2019)

Relationship between gene expression profile class and tumor thickness regression after plaque brachytherapy for choroidal melanoma
por: Sharma, Arjun, et al.
Publicado: (2022)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Role of intravitreal brolucizumab with intravitreal rtPA and pneumatic displacement for submacular hemorrhage: A case series
por: Chakraborty, Debdulal, et al.
Publicado: (2022)

Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid
por: Bilgic, Alper, et al.
Publicado: (2021)

Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
por: Maggio, Emilia, et al.
Publicado: (2022)

Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma
por: AlMahmoud, Tahra, et al.
Publicado: (2018)

Complications and adverse events of plaque brachytherapy for ocular melanoma
por: Peddada, Krishi V., et al.
Publicado: (2019)

Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma
por: Correa-Pérez, María Encarnación, et al.
Publicado: (2013)

Early OCTA Changes of Type 3 Macular Neovascularization Following Brolucizumab Intravitreal Injections
por: Gigon, Anthony, et al.
Publicado: (2022)

Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series
por: Chakraborty, Somnath, et al.
Publicado: (2022)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

Annulus-shaped I-125 plaque brachytherapy for conjunctival melanoma
por: Berkowitz, Sean T., et al.
Publicado: (2022)

Longitudinal optical coherence tomography angiography (OCT-A) in a patient with radiation retinopathy following plaque brachytherapy for uveal melanoma
por: Binkley, Elaine M., et al.
Publicado: (2022)

Brolucizumab and immunogenicity
por: Sharma, Ashish, et al.
Publicado: (2020)

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2021)

Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations
por: Jain, Atul, et al.
Publicado: (2020)

Durability of VEGF Suppression With Intravitreal Aflibercept and Brolucizumab: Using Pharmacokinetic Modeling to Understand Clinical Outcomes
por: Eissing, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ghu4n6q097tipdf8nqp0s377nu